Relpax and Diskitis - a phase IV clinical study of FDA data

Summary:

We study 9,268 people who take Relpax (eletriptan hydrobromide) or have Diskitis. No report of Diskitis is found in people who take Relpax.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Diskitis?

Diskitis: no further information found.

On Nov, 19, 2025

No report is found.

Do you take Relpax and have Diskitis?

- Check whether Diskitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Relpax:

Relpax (9,259 reports)

Diskitis treatments and more:

Diskitis (9 reports)

How severe was Diskitis and when was it recovered:

Diskitis in Relpax

Expand to all the drugs that have ingredients of eletriptan hydrobromide:

Diskitis and drugs with ingredients of eletriptan hydrobromide

Browse all side effects of Relpax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diskitis:

Diskitis

Browse all the conditions that are associated with Diskitis:

Diskitis

Drugs similar to Relpax and Diskitis :

How the study uses the data?

The study uses data from the FDA. It is based on eletriptan hydrobromide (the active ingredients of Relpax) and Relpax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.